A carregar...
Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells
Colorectal cancer (CRC) is a common and life-threatening type of malignant cancer, which is associated with a high mortality rate. Cisplatin (CDDP) is a commonly used chemotherapy drug with significant side effects. Brusatol (BR) is one of the principal chemical compounds isolated from the Chinese h...
Na minha lista:
| Publicado no: | Int J Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5819912/ https://ncbi.nlm.nih.gov/pubmed/29328398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3372 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|